Compounded semaglutide
Sold by Whoosh Wellness · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$149
| Medication · Monthly plan, Microdose Injection method | $149 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Monthly plan, Microdose Injection method “GLP-1 Compounded Semaglutide Starting At $149 /mo $169 /mo Choose a method Microdose Injection Injection” | Per month$149 | Charged today$149 |
| Monthly plan, full-dose Injection method “GLP-1 Compounded Semaglutide Starting At $149 /mo $169 /mo Choose a method Microdose Injection Injection” | Per month$169 | Charged today$169 |
We earn nothing from this link. Whoosh Wellness has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “Fees for services are disclosed on the website. By providing your payment information, you authorize Whoosh Wellness and its payment processors to charge you for applicable services, including subscriptions if applicable. Subscription services may automatically renew unless canceled prior to the next billing cycle.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from whooshwellness.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The only states statement found is an EXCLUSION list for one specific pharmacy partner's ability to dispense STERILE COMPOUNDS ('cannot dispense sterile compounds... in the following US states: CALIFORNIA, NEVADA, NEW JERSEY, ALABAMA, and ARKANSAS'), not a company-wide coverage statement, so per the brief's rule states.list was left empty rather than recorded as an inverted 45-state coverage claim. The /pricing page's tab control (Monthly / 3-Month / 6-Month) rendered all three tabs' content flattened into one block of visible text with no labels distinguishing which price block belongs to which tab; only the FIRST block (used above, apparently the default 'Monthly' tab) could be confidently attributed to a 1-month term. Two further blocks of larger numbers followed for every product (e.g. semaglutide also showed '$299 /mo $399 /mo' and then '$499 /mo $699 /mo') that this tool's text extraction could not reliably tie to a specific plan length, so they were NOT recorded as separate priced entries. Separately, the semaglutide PRODUCT page (not the /pricing page) advertises different numbers entirely: 'Starting as low as $83 $116' (https://whooshwellness.com/products/compounded-semaglutide), and the tirzepatide product page shows 'Starting as low as $125 $166 $166' (https://whooshwellness.com/products/compounded-tirzepatide) -- neither of which matches the /pricing page's $149/$169 and $199/$249 monthly figures for the same drugs. This is a real cross-page price inconsistency on Whoosh's own site that a reader relying on only one of the two pages would not see.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.